Correction: Canar et al. STAT2 Promotes Tumor Growth in Colorectal Cancer Independent of Type I IFN Receptor Signaling. Curr. Oncol. 2025, 32, 707
Current Oncology · 04.11.2026 · 33 (11) · 675
DOI: 10.3390/curroncol33110675 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, online erschienen am 04.11.2026. Verfasst von Jorge Canar und 5 weiteren Autor:innen. Die Arbeit nennt 1 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Cancer Institute, National Institute of General Medical Sciences.
Abstract (Originalsprache)
In the original publication [...]
Förderung
- National Cancer Institute
- National Institute of General Medical Sciences
Zitieren
APA
Canar, J., Bono, M., Alvarado, A., Slifker, M., Sitia, G., & Gamero, A. M. (2026). Correction: Canar et al. STAT2 Promotes Tumor Growth in Colorectal Cancer Independent of Type I IFN Receptor Signaling. Curr. Oncol. 2025, 32, 707. Current Oncology, 33(11), 675. https://doi.org/10.3390/curroncol33110675
Vancouver
Canar J, Bono M, Alvarado A, Slifker M, Sitia G, Gamero AM. Correction: Canar et al. STAT2 Promotes Tumor Growth in Colorectal Cancer Independent of Type I IFN Receptor Signaling. Curr. Oncol. 2025, 32, 707. Current Oncology. 2026;33(11):675. doi:10.3390/curroncol33110675
BibTeX
@article{Canar2026,
author = {Canar, Jorge and Bono, Madeline and Alvarado, Amy and Slifker, Michael and Sitia, Giovanni and Gamero, Ana M.},
title = {Correction: Canar et al. STAT2 Promotes Tumor Growth in Colorectal Cancer Independent of Type I IFN Receptor Signaling. Curr. Oncol. 2025, 32, 707},
journal = {Current Oncology},
year = {2026},
volume = {33},
number = {11},
pages = {675},
doi = {10.3390/curroncol33110675}
}
EUVIMED